Original article by Jessica Gardner
The Australian Financial Review – Page: 13 : 7-Jan-15
The shares of Medibank Private on 6 January 2015 closed 1.7% lower at $A2.35. The health insurer was recently floated with an issue price of $A2.15 for institutional investors and $A2 for small retail ones. Most analysts have placed negative or neutral recommendations on the stock, and the consensus price target is $A2.30. However Tim Lawson of Macquarie Bank is more bullish with $A2.62 and a "buy" rating, while Bank of America Merrill Lynch’s Toby Langley also recommends accumulating the stock and predicts it to reach $A3
CORPORATES
MEDIBANK PRIVATE LIMITED – ASX MPL, MERRILL LYNCH (AUSTRALIA) PTY LTD, BANK OF AMERICA AUSTRALIA LIMITED, MACQUARIE BANK LIMITED – ASX MBL, RAMSAY HEALTH CARE LIMITED – ASX RHC, HEALTHSCOPE LIMITED – ASX HSO, INSURANCE AUSTRALIA GROUP LIMITED – ASX IAG, SUNCORP GROUP LIMITED – ASX SUN
